SELLAS Life Sciences Group, Inc. (SLS)
Pharmaceutical Preparations
Latest Price
$10.01
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.62
P/B Ratio
16.08
Institutional Ownership
33.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.20M | $51.0M | 6.73% | +4.66M | 2026-03-31 |
| STATE STREET CORP | 8.40M | $35.0M | 4.63% | +6.21M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.53M | $31.0M | 4.15% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 4.88M | $20.0M | 2.69% | +2.89M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.91M | $16.0M | 2.16% | +835.3K | 2026-03-31 |
| MARSHALL WACE, LLP | 2.04M | $8.0M | 1.12% | +696.5K | 2026-03-31 |
| JONES FINANCIAL COMPANIES LLLP | 1.68M | $7.0M | 0.92% | +1.25M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.46M | $6.0M | 0.81% | -- | 2026-03-31 |
| MORGAN STANLEY | 1.34M | $5.0M | 0.74% | +445.4K | 2026-03-31 |
| NORTHERN TRUST CORP | 1.28M | $5.0M | 0.70% | +345.2K | 2026-03-31 |